Related Experiment Video
Updated: Apr 30, 2026

Investigating von Willebrand Factor Pathophysiology Using a Flow Chamber Model of von Willebrand Factor-platelet String Formation
Published on: August 14, 2017
Concomitant acquired and inherited von Willebrand disease: A challenging bleeding disorder
Nikita J Sareen1, Kenneth D Friedman2,3, Mia J Sullivan2
1Division of Hematology Oncology, Department of Medicine, Weill Cornell Medicine/New York Presbyterian Hospital, New York, New York, USA.
Background:
Inherited von Willebrand disease is the most common inherited bleeding disorder and is characterized by mucocutaneous bleeding resulting from impaired platelet adhesion and aggregation at sites of vascular injury. Acquired von Willebrand disease is an often-underrecognized bleeding disorder caused by structural or functional abnormalities of von Willebrand factor secondary to autoimmune, lymphoproliferative, myeloproliferative, plasma cell dyscrasias, malignancy, cardiovascular, or other systemic disorders. The coexistence of inherited and acquired von Willebrand disease should be suspected in patients with a previously stable bleeding phenotype who develop unexplained clinical worsening and requires a high index of clinical suspicion. This scenario presents a significant diagnostic challenge, as laboratory findings may be similar between inherited and acquired forms.
Case Report:
96-year-old woman with known type 2A von Willebrand disease and a previously mild bleeding phenotype who developed worsening bleeding due to acquired von Willebrand disease secondary to previously unrecognized severe aortic stenosis. Genetic sequencing identified a germline variant in exon 28 and an acquired variant in exon 31. Transcatheter aortic valve replacement resulted in rapid improvement of the bleeding phenotype and discontinuation of replacement therapy.
Conclusion:
This case underscores the importance of considering acquired von Willebrand disease in patients with inherited von Willebrand disease who present with new-onset or worsening bleeding symptoms, as early recognition enables targeted treatment of the underlying condition and may significantly improve clinical outcomes.
More Related Videos
13:08Measurement of Factor V Activity in Human Plasma Using a Microplate Coagulation Assay
Published on: September 9, 2012
09:36Modified Heterotopic Hindlimb Osteomyocutaneous Flap Model in the Rat for Translational Vascularized Composite Allotransplantation Research
Published on: April 26, 2019
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Formation of the Platelet Plug
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Blood Transfusion and Agglutination
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
Hemorrhagic Stroke ll: Pathophysiology